Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Diamedica Therapeutics Inc (NQ: DMAC ) 4.270 +0.130 (+3.14%) Streaming Delayed Price Updated: 1:16 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Diamedica Therapeutics Inc < Previous 1 2 Next > DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024 August 07, 2024 DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q1 2024 May 08, 2024 DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023 March 19, 2024 DMAC stock results show that DiaMedica Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Recap: DiaMedica Therapeutics Q4 Earnings March 19, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday October 25, 2023 Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning. Via InvestorPlace Earnings Preview: DiaMedica Therapeutics May 12, 2023 Via Benzinga DiaMedica Therapeutics's Earnings Outlook March 27, 2023 Via Benzinga FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial - Read Why July 07, 2022 Via Benzinga Earnings Scheduled For November 13, 2023 November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. Via Benzinga Earnings Outlook For DiaMedica Therapeutics November 10, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023 June 22, 2023 Via Benzinga DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199 June 21, 2023 DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a Via Benzinga $1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying December 02, 2022 The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... Via Benzinga Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday October 28, 2022 Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also... Via Benzinga Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday October 07, 2022 Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. Via Benzinga DiaMedica Therapeutics: Q2 Earnings Insights August 10, 2022 DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Via Benzinga Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session October 06, 2022 Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga DiaMedica Therapeutics Earnings Preview August 09, 2022 DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Via Benzinga 3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More July 22, 2022 U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... Via Benzinga This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday July 08, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market. Via Benzinga Nasdaq Surges 250 Points; Crude Oil Rises Sharply July 07, 2022 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims. Via Benzinga Stocks That Hit 52-Week Lows On Thursday July 07, 2022 Thursday's session saw 49 companies set new 52-week lows. Via Benzinga Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue July 07, 2022 U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims. Via Benzinga This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session July 07, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp. Via Benzinga Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims July 07, 2022 U.S. stocks traded higher this morning, following the release of data on initial jobless claims. Via Benzinga The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill July 07, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 July 07, 2022 Upgrades Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday July 07, 2022 Good morning, trader! We're taking a look at the biggest pre-market stock movers for Thursday that investors need to know about! Via InvestorPlace Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session July 07, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.